Obesity negatively affects brain function, particularly in patients with type 2 diabetes.
Highlights from the 99th Annual Meeting & Expo of the Endocrine Society.
Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.
Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.
Marie E. McDonnell, MD, of Brigham & Women’s Hospital, Boston, Massachusetts, discusses implementing effective behavior change for patients with diabetes.
Andrew Ahmann, MD, discusses the Endocrine Society’s new updates on diabetes technology.
Megan Haymart, MD, discusses new ATA guidelines for radioactive iodine treatment in thyroid cancer.
Jonathan LoPresti, MD, PhD, discusses the challenges of taking thyroglobulin measurements at ENDO 2016.
Rocio Pereira, MD, discusses the association between diabetes and infectious diseases in developing countries.
Douglas Ross, MD, discusses changes in ATA guidelines regarding the treatment of hyperthyroidism.